Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ivenix
MedTech
Fresenius Kabi faces another Class I infusion pump recall
For the third time since 2022, Fresenius Kabi has earned a Class I rating from the FDA for a recall of its Ivenix medication delivery technology.
Andrea Park
Jan 16, 2024 12:45pm
Fresenius Kabi recalls newly acquired infusion pump system
Apr 20, 2023 10:29am
Fresenius Kabi nabs smart infusion pump maker Ivenix for $240M
Mar 31, 2022 12:36pm
Bluebird picks up Heffron as European chief—Chutes & Ladders
Jan 17, 2020 9:30am
Ivenix taps new CEO as it brings its infusion pump to market
Jan 13, 2020 11:00am
Ivenix bags first of $50M for next-gen infusion pump
Mar 22, 2017 11:29am
